Components:
Method of action:
Treatment option:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 19.03.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Scholl Athletes Foot Powder
Superdrug Athletes Foot Powder
Tolnaftate 1.0%w/w
Powder for topical application
For the prevention and treatment of Athlete's Foot.
Wash and dry infected area, and apply twice daily or as directed by your doctor. Dust feet liberally, especially between toes. For added protection dust on socks, hosiery and inside shoes. Continue treatment for two weeks after symptoms disappear.
Not recommended for nail or scalp infections.
For external use only
Keep out of eyes
If symptoms do not improve within 10 days, discontinue use and consult your doctor
Keep out of the reach and sight of children
None stated.
|
Adverse reactions have been ranked under headings of frequency using the following convention: | ||
|
Very common |
> 1/10 | |
|
Common |
> 1/100 to > 1/10 | |
|
Uncommon |
> 1/1,000 to < 1/100 | |
|
Rare |
> 1/10,000 to < 1/1,000 | |
|
Very rare |
<1/10,000 | |
|
Within easy frequency grouping, undesirable effects are presented in order of decreasing seriousness. | ||
|
System Organ Class |
Frequency | |
|
Skin and subcutaneous tissue disorder |
Unknown |
Skin reactions Skin irritation Pruritis Contact dermatitis |
Not relevant to topical use.
Tolnaftate
Topical antifungal agent (ATC Classification: D01AE 18)
Not applicable for a topical dosage form of this type
None stated
Talc
Starch
None stated.
24 months, unopened
Once opened, use within 6 months
Store below 25°C.
High density poly-ethylene container with sifter assembly. 75g of product
No special precautions required
Scholl Consumer Products Ltd
103-105 Bath Road
Slough
SL1 3UH
UK
PL 00587/0007
24/04/1985 / 12/01/2005
19/09/2016
- Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
- Molecular Docking-Guided Ungual Drug-Delivery Designfor Amelioration of Onychomycosis
- The solid-state conformation of the topical antifungal agent O-naphthalen-2-yl N-methyl- N-(3-methylphenyl)carbamothioate
- Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciatawith potent antihyperlipidaemic activity
- Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review
- Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women
Update on therapy for superficial mycoses: review article partI *
- Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals
- Therapy of Skin, Hair and Nail Fungal Infections
- Hydroxychavicol: A phytochemical targeting cutaneous fungal infections
- Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
- Molecular Docking-Guided Ungual Drug-Delivery Designfor Amelioration of Onychomycosis
- The solid-state conformation of the topical antifungal agent O-naphthalen-2-yl N-methyl- N-(3-methylphenyl)carbamothioate
- Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciatawith potent antihyperlipidaemic activity
- Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review
- Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women
Update on therapy for superficial mycoses: review article partI *
- Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals
- Therapy of Skin, Hair and Nail Fungal Infections
- Hydroxychavicol: A phytochemical targeting cutaneous fungal infections
